Guest editors : Giuseppe Leone and Lodovico Balducci
Table of Contents
Perspectives
| TREATMENT OF CANCER IN THE OLDER AGED PERSON | PDF HTML |
| Lodovico Balducci | e2010029 |
Review Articles
| ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION | PDF HTML |
| Mohamed L. Sorror, Rainer F. Storb | e2010015 |
| CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH | PDF HTML |
| Lisa Pieri, Paola Guglielmelli, Alessandro Maria Vannucchi | e2010017 |
| OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING REDUCED-INTENSITY CONDITIONINIG REGIMEN IN PATIENTS WITH IDIOPATHIC MYELOFIBROSIS: THE G.I.T.M.O. EXPERIENCE AND REVIEW OF THE LITERATURE | PDF HTML |
| Francesca Patriarca, Andrea Bacigalupo, Alessandra Sperotto, Miriam Isola, Maria Teresa Van Lint, Anna Paola Iori, Paolo Di Bartolomeo, Maurizio Musso, Pietro Pioltelli, Giuseppe Visani, Pasquale Iacopino, Renato Fanin, Alberto Bosi | e2010010 |
| APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA | PDF HTML |
| Tadeusz Robak | e2010011 |
| ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA | PDF HTML |
| Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Federica Sorà, Simona Sica | e2010026 |
| THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT | PDF HTML |
| Paul Richardson, Jacob Laubach, Anuj Mahindra, Constantine Mitsiades, Robert Schlossman, Irene Ghobrial, Teru Hideshima, Noopur Raje, Nikhil Munshi, Kenneth Anderson | e2010009 |
| "ROLE OF ALLOGENEIC TRANSPLANTATION IN MULTIPLE MYELOMA IN THE ERA OF NEW DRUGS" | PDF HTML |
| Benedetto Bruno, Luisa Giaccone, Moreno Festuccia, Mario Boccadoro | e2010013 |
| NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES | PDF HTML |
| Francesco D'Alò, Mariangela Greco, Marianna Criscuolo, Maria Teresa Voso | e2010021 |
| ROLE AND TIMING OF HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME | PDF HTML |
| Teresa L Field, Claudio Anasetti | e2010019 |
How I Treat
| ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN THE TREATMENT OF CHRONIC LYMPHOCITIC LEUKEMIA : WHY AND WHEN ? | PDF HTML |
| Maria L. Delioukina, Stephen J. Forman | e2010018 |
Original Articles
| POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE | PDF HTML |
| Guillermo Jose Ruiz-Delgado, Avril Lopez-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo Jose Ruiz-Argüelles | e2010016 |
| CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY | PDF HTML |
| Daichi Inoue, Hayato Maruoka, Takayuki Takahashi | e2010020 |
Case Reports
| PHENYTOIN-ASSOCIATED LYMPHOADENOPATHY MIMICKING A PERIPHERAL T-CELL LYMPHOMA | PDF HTML |
| Mark E. Johns, Lynn C. Moscinski, Lubomir Sokol | e2010028 |
Letters to Editor
| Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia | PDF HTML |
| Alhossain A. Khalafallah, Bernadene Fernandopulle, Terry Brain | e2010012 |
Mediterr J Hematol Infect Dis ISSN 2035-3006